Monitoring method and apparatus
First Claim
Patent Images
1. A device for monitoring cardiac health comprising a detector configured to measure, in a sample taken from a patient, a level of a first biomarker selected from the group consisting of:
- a marker of left ventricular volume overload or myocardial stretch, a marker of myocardial apoptosis or injury, a marker of myocardial ischemia, a marker of inflammation, a marker of anemia, a marker of renal function, a marker of electrolyte balance, and a marker of sodium retention.
2 Assignments
0 Petitions
Accused Products
Abstract
A device for remote management of patients suffering from heart failure and hypertension can measure one or more biomarker. The device aids in monitoring the efficacy and safety of treatment in such patients.
-
Citations
50 Claims
-
1. A device for monitoring cardiac health comprising a detector configured to measure, in a sample taken from a patient, a level of a first biomarker selected from the group consisting of:
- a marker of left ventricular volume overload or myocardial stretch, a marker of myocardial apoptosis or injury, a marker of myocardial ischemia, a marker of inflammation, a marker of anemia, a marker of renal function, a marker of electrolyte balance, and a marker of sodium retention.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)
-
30. A method of monitoring a patient comprising measuring in a sample taken from a patient, a level of a first biomarker selected from the group consisting of:
- a marker of left ventricular volume overload or myocardial stretch, a marker of myocardial apoptosis or injury, a marker of myocardial ischemia, a marker of inflammation, a marker of anemia, a marker of renal function, a marker of electrolyte balance, and a marker of sodium retention.
- View Dependent Claims (31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)
-
42. A health care kit comprising:
-
a test cartridge including a sample port and a first assay, wherein the first assay recognizes a marker of left ventricular volume overload or myocardial stretch, a marker of myocardial apoptosis or injury, a marker of myocardial ischemia, a marker of inflammation, a marker of anemia, a marker of renal function, a marker of electrolyte balance, or a marker of sodium retention; and
a device including a detector configured to measure a level of the biomarker recognized by the assay. - View Dependent Claims (43, 44, 45, 46, 47, 48, 49, 50)
-
Specification